<DOC>
	<DOCNO>NCT00594152</DOCNO>
	<brief_summary>Investigators goal optimize glycemic blood pressure control saw type 1 diabetic patient weekly . A control group receive 3-4 subcutaneous insulin injection per day ; intravenous insulin pulse infusion group receive , addition , three one hour infusion pulsatile fashion one eight hour period week . Patients follow 12 month periodic test renal function repeat blood urinary analysis ; diabetes control blood test diabetes impact measurement score ; cardiac autonomic function echocardiography , 24 hour electrocardiographic testing ; visual change repeat fundus photography . The study hypothesis correction respiratory quotient would correct defect lead microvascular complication diabetes ( Type 1 ) .</brief_summary>
	<brief_title>Anti-Nephropathic Effects Chronic Intermittent Intravenous Insulin Therapy ( CIIIT )</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetic proteinuria willing see weekly evaluation renal function Associated active medical disease would permit evaluation stable renal disease 18 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Diabetic autonomic neuropathy</keyword>
</DOC>